Feedback / Questions
FT011 - Certa Therap
https://www.biospace.com/article/releases/certa-therapeutics-presents-positive-data-from-a-phase-2-clinical-study-highlighting-the-potential-benefit-of-ft011-as-a-novel-treatment-for-scleroderma/?s=68
Chris Denton; Dinesh Khanna; Darren Kelly
Nov 15, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next